CITALOPRAM HYDROBROMIDE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for citalopram hydrobromide and what is the scope of patent protection?

Citalopram hydrobromide is the generic ingredient in two branded drugs marketed by Almatica, Norvium Bioscience, Forest Labs, Aurobindo Pharma, Chartwell Molecular, Hetero Labs Ltd Iii, Hikma, Pharm Assoc, Biovail Labs Intl, Abbvie, Amneal Pharms Ny, Apotex, Aurobindo, Chartwell Rx, Cosette, Dr Reddys Labs Ltd, Epic Pharma, Epic Pharma Llc, Fosun Pharma, Glenmark Pharms Ltd, Heritage Pharma, Invagen Pharms, Jubilant Generics, Mylan, Natco Pharma Ltd, Roxane, Sun Pharm Inds Inc, Sun Pharm Industries, Taro, and Torrent Pharms, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-eight drug master file entries for citalopram hydrobromide. Forty-four suppliers are listed for this compound.

Summary for CITALOPRAM HYDROBROMIDE

US Patents:	0
Tradenames:	2
Applicants:	30
NDAs:	36
Drug Master File Entries:	28
Finished Product Suppliers / Packagers:	44
Raw Ingredient (Bulk) Api Vendors:	132
Clinical Trials:	12
Patent Applications:	2,710
Drug Prices:	Drug price trends for CITALOPRAM HYDROBROMIDE
Drug Sales Revenues:	Drug sales revenues for CITALOPRAM HYDROBROMIDE
What excipients (inactive ingredients) are in CITALOPRAM HYDROBROMIDE?	CITALOPRAM HYDROBROMIDE excipients list
DailyMed Link:	CITALOPRAM HYDROBROMIDE at DailyMed

See drug prices for CITALOPRAM HYDROBROMIDE

Drug Sales Revenue Trends for CITALOPRAM HYDROBROMIDE

See drug sales revenues for CITALOPRAM HYDROBROMIDE

Recent Clinical Trials for CITALOPRAM HYDROBROMIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 3
Haining Health-Coming Biotech Co., Ltd.	Phase 2
Alphacait, LLC	Phase 2

See all CITALOPRAM HYDROBROMIDE clinical trials

Pharmacology for CITALOPRAM HYDROBROMIDE

Drug Class	Serotonin Reuptake Inhibitor
Mechanism of Action	Serotonin Uptake Inhibitors

Medical Subject Heading (MeSH) Categories for CITALOPRAM HYDROBROMIDE

Antidepressive Agents, Second-Generation
Serotonin Uptake Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for CITALOPRAM HYDROBROMIDE

N06AB	Selective serotonin reuptake inhibitors
N06A	ANTIDEPRESSANTS
N06	PSYCHOANALEPTICS
N	Nervous system

US Patents and Regulatory Information for CITALOPRAM HYDROBROMIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharm Assoc	CITALOPRAM HYDROBROMIDE	citalopram hydrobromide	SOLUTION;ORAL	077601-001	Nov 15, 2005		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	CITALOPRAM HYDROBROMIDE	citalopram hydrobromide	TABLET;ORAL	077037-002	Nov 5, 2004		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Epic Pharma Llc	CITALOPRAM HYDROBROMIDE	citalopram hydrobromide	TABLET;ORAL	077036-002	Oct 28, 2004		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Taro	CITALOPRAM HYDROBROMIDE	citalopram hydrobromide	TABLET;ORAL	077278-002	Mar 22, 2006		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Epic Pharma Llc	CITALOPRAM HYDROBROMIDE	citalopram hydrobromide	TABLET;ORAL	077036-001	Oct 28, 2004		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Heritage Pharma	CITALOPRAM HYDROBROMIDE	citalopram hydrobromide	TABLET;ORAL	077232-001	Oct 31, 2005		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hikma	CITALOPRAM HYDROBROMIDE	citalopram hydrobromide	SOLUTION;ORAL	077043-001	Dec 13, 2004	AA	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.